Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4

Documenti analoghi

• Cover Feature: Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4 (ChemMedChem 6/2025)
  di: Raghuvir H. Gaonkar, et al.
  Pubblicazione: (2025)
• Synthesis and Biological Characterization of 4,4‐Difluoro‐3‐(phenoxymethyl)piperidine Scaffold as Dopamine 4 Receptor (D 4 R) Antagonist in vitro Tool compounds
  di: Saeedeh Saeedi, et al.
  Pubblicazione: (2025)
• Synthesis and Evaluation of Fluorinated Peptidomimetics Enabling the Development of 18 F‐Labeled Radioligands Targeting Muscarinic Acetylcholine Receptor Subtype M3
  di: Miguel A. Herrera‐Rueda, et al.
  Pubblicazione: (2025)
• Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
  di: Isabelle Lyothier, et al.
  Pubblicazione: (2025)
• Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1
  di: Max E. Huber, et al.
  Pubblicazione: (2024)